Shirlyn Adkins (@shirlynadkins) 's Twitter Profile
Shirlyn Adkins

@shirlynadkins

@AANEMorg Executive Director of the AANEM & American Neuromuscular Foundation- tweeting items related to neuromuscular and electrodiagnostic medicine.

ID: 1117634934

linkhttps://www.neuromuscularfoundation.org/home calendar_today24-01-2013 20:09:56

2,2K Tweet

944 Followers

744 Following

Shirlyn Adkins (@shirlynadkins) 's Twitter Profile Photo

The field of NM medicine is growing and this is an exciting time for both neurologists and PMR physicians to consider this amazing area of medicine!

AANEM (@aanemorg) 's Twitter Profile Photo

Find your perfect neuromuscular fellowship match through the AANEM Fellowship Match Portal! 💪🧠 Applications will be released to institutions on March 1, so find your match today! 🧩 Explore the match portal 👉 ow.ly/23k850V2pFX #AANEM #NeuromuscularMedicine #AANEMMatch

Find your perfect neuromuscular fellowship match through the AANEM Fellowship Match Portal! 💪🧠 Applications will be released to institutions on March 1, so find your match today! 🧩

Explore the match portal 👉 ow.ly/23k850V2pFX

#AANEM #NeuromuscularMedicine #AANEMMatch
Shirlyn Adkins (@shirlynadkins) 's Twitter Profile Photo

Please consider giving. Remember 100% of your donation is used to fund researchers or awards! Thanks to AANEM which pays all the administrative costs!

Shirlyn Adkins (@shirlynadkins) 's Twitter Profile Photo

Training Program Directors and Residents and Fellows. Check out this great podcast showing how others are using AANEM's TPP to help them succeed! Listen now: spotifycreators-web.app.link/e/OyZoYurcQRb #aanempodcast #EDX #NeuromuscularMedicine

Training Program Directors and Residents and Fellows. 
 Check out this great podcast showing how others are using <a href="/AANEMorg/">AANEM</a>'s TPP to help them succeed!
Listen now: spotifycreators-web.app.link/e/OyZoYurcQRb
#aanempodcast #EDX #NeuromuscularMedicine
Shirlyn Adkins (@shirlynadkins) 's Twitter Profile Photo

The FDA approved expanding the indication of Alexion/AstraZeneca’s eculizumab (Soliris) for pediatric patients 6 years & older w generalized myasthenia gravis who are AChR antibody positive. It is the first & only treatment available for pediatric patients living w this disease.

Shirlyn Adkins (@shirlynadkins) 's Twitter Profile Photo

Congratulations to Dr. Brett Morrison for receiving an American Neuromuscular Foundation Research Grant for his project, “Role of Macrophage MCT1 in Diabetic Peripheral Neuropathy. Donate Today! Remember 100% of your donation goes to support research & education. neuromuscularfoundation.org/donate

Congratulations to Dr. Brett Morrison for receiving  an <a href="/AmNmFoundation/">American Neuromuscular Foundation</a> Research Grant for his project, “Role of Macrophage MCT1 in Diabetic Peripheral Neuropathy. Donate Today! Remember 100% of your donation goes to support research &amp; education. neuromuscularfoundation.org/donate
Shirlyn Adkins (@shirlynadkins) 's Twitter Profile Photo

Check out all these amazing women presenting during the AANEM's Plenary Session. Be sure to save the date for what is going to be an amazing meeting in San Fran! Wednesday Oct 20 to Saturday Nov 1, 2025!

Check out all these amazing women presenting during the <a href="/AANEMorg/">AANEM</a>'s Plenary Session.  Be sure to save the date for what is going to be an amazing meeting in San Fran! Wednesday Oct 20 to Saturday Nov 1, 2025!
Shirlyn Adkins (@shirlynadkins) 's Twitter Profile Photo

The FDA Approved VYVGART Hytrulo Prefilled Syringe for Self-Injection in Generalized Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyneuropathy! argenx.com/news/2024/arge… argenx

Amylyx (@amylyxpharma) 's Twitter Profile Photo

Today, we announced that the FDA has granted Fast Track designation to our investigational ASO therapy for the treatment of ALS, which is currently being studied in the Phase 1 LUMINA trial. Early cohort data from LUMINA is expected in 2025. We are committed to advancing this

Sarepta Therapeutics (@sarepta) 's Twitter Profile Photo

News: The U.S. FDA granted Platform Technology Designation to SRP-9003, Sarepta’s investigational gene therapy for the treatment of LGMD type 2E/R4. This is one of the first programs to receive the technology designation. Read more at Sarepta.com.

News: The U.S. FDA granted Platform Technology Designation to SRP-9003, Sarepta’s investigational gene therapy for the treatment of LGMD type 2E/R4. This is one of the first programs to receive the technology designation. Read more at Sarepta.com.
Shirlyn Adkins (@shirlynadkins) 's Twitter Profile Photo

Congratulations to everyone that matched through the AANEM's fellowship portal! We are excited to have you join our field. There are still spots open for those of you still looking to make a match. See the NM and CNP opening at aanem.org/clinical-pract…!

Congratulations to everyone that matched through the <a href="/AANEMorg/">AANEM</a>'s fellowship portal!  We are excited to have you join our field.  There are still spots open for those of you still looking to make a match.  See the NM and CNP opening at aanem.org/clinical-pract…!
Shirlyn Adkins (@shirlynadkins) 's Twitter Profile Photo

Look at the amazing all female line up for the AANEM Plenary Session! See you all in San Fran Oct 29-Nov 1. Registration opens soon. Don't miss out!

Look at the amazing all female line up for the <a href="/AANEMorg/">AANEM</a> Plenary Session!  See you all in San Fran Oct 29-Nov 1.  Registration opens soon. Don't miss out!